
| Dosaggio del prodotto: 0.1mg | |||
|---|---|---|---|
| Confezione (n.) | Per compresse | Prezzo | Acquista |
| 10 | €3.42 | €34.16 (0%) | 🛒 Aggiungi al carrello |
| 20 | €1.92 | €68.32 €38.43 (44%) | 🛒 Aggiungi al carrello |
| 30 | €1.42 | €102.48 €42.70 (58%) | 🛒 Aggiungi al carrello |
| 90 | €0.57 | €307.43 €51.24 (83%) | 🛒 Aggiungi al carrello |
| 120 | €0.46 | €409.91 €55.51 (86%) | 🛒 Aggiungi al carrello |
| 180 | €0.33 | €614.86 €59.78 (90%) | 🛒 Aggiungi al carrello |
| 270 | €0.25 | €922.29 €68.32 (93%) | 🛒 Aggiungi al carrello |
| 360 | €0.23
Migliore per compresse | €1229.73 €81.13 (93%) | 🛒 Aggiungi al carrello |
Sinonimi
| |||
More info:
Popular Products
Alphagan: Effective IOP Reduction for Glaucoma Management - Evidence-Based Review
Product Description Alphagan, generically known as brimonidine tartrate, is a topical ophthalmic solution classified as a selective alpha-2 adrenergic receptor agonist. It is not a dietary supplement but a prescription medical device/drug, specifically an IOP-lowering agent indicated for the management of open-angle glaucoma and ocular hypertension. It functions by reducing the production of aqueous humor within the ciliary body and increasing uveoscleral outflow, thereby lowering intraocular pressure (IOP), which is the primary modifiable risk factor in glaucomatous optic neuropathy.
Amaryl: Effective Glycemic Control for Type 2 Diabetes - Evidence-Based Review
Product Description Amaryl, known generically as glimepiride, is a modern sulfonylurea oral antihyperglycemic agent. It is classified as a third-generation sulfonylurea and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Unlike older sulfonylureas, glimepiride demonstrates a more pancreas-selective action with potentially lower cardiovascular risk and a once-daily dosing regimen that enhances patient adherence. It works primarily by stimulating the release of insulin from functional pancreatic beta cells.
Betapace: Effective Rhythm Control for Atrial and Ventricular Arrhythmias - Evidence-Based Review
Product Description Betapace, known generically as sotalol hydrochloride, is a class III antiarrhythmic agent with additional beta-adrenergic blocking (class II) properties. It is not a dietary supplement or a medical device, but a prescription medication approved for the treatment of documented, life-threatening ventricular arrhythmias and for the maintenance of normal sinus rhythm in patients with symptomatic atrial fibrillation or atrial flutter. It exists in both non-β-blocking (racemic) and β-blocking forms, with its antiarrhythmic efficacy primarily attributed to its potassium channel blockade, which prolongs the cardiac action potential duration and refractory period.
Effexor XR
Product Description: Effexor XR is an extended-release capsule formulation of venlafaxine hydrochloride, a serotonin-norepinephrine reuptake inhibitor (SNRI). It is indicated for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder (PD) with or without agoraphobia in adults. The extended-release mechanism allows for once-daily dosing, designed to provide steady plasma concentrations of the active moiety, O-desmethylvenlafaxine (ODV). 1. Introduction: What is Effexor XR?
Flexeril
Let’s talk about Flexeril. It’s one of those drugs that’s been in the toolkit for decades—since the 70s, actually—and you either have a comfort zone with it or you’ve seen enough side effects to be wary. Officially, it’s cyclobenzaprine hydrochloride, a centrally-acting skeletal muscle relaxant. But in the trenches of primary care and ortho clinics, it’s that script we reach for when a patient hobbles in with an acute back spasm, often after a weekend of overdoing it.
Lopressor (Metoprolol Tartrate): Targeted Cardiovascular Protection for Hypertension and Angina - Evidence-Based Review
Product Description: Lopressor is the brand name for metoprolol tartrate, a cardioselective beta-1 adrenergic receptor blocker. It is available in immediate-release tablets (25 mg, 50 mg, 100 mg) and is primarily indicated for the management of hypertension, angina pectoris, and in the early treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. It works by antagonizing catecholamine effects on the heart, reducing heart rate, myocardial contractility, and blood pressure.
Propranolol SR
Let’s talk about Propranolol SR. In my practice, it’s one of those foundational tools that never really left the toolkit, even with all the newer agents that have come along. We’re discussing the sustained-release formulation of propranolol hydrochloride. It’s not a dietary supplement; it’s a prescription medication, a non-selective beta-adrenergic receptor blocker. The “SR” is the critical part—it stands for Sustained Release, meaning the tablet is engineered to release the active drug slowly and continuously over about 24 hours.
Serpina: Natural Support for Neurogenic Blood Pressure and Stress Response
Product Description Serpina is a standardized botanical extract derived from the root of Rauwolfia serpentina, a plant with a long history of use in traditional systems of medicine. In modern clinical practice, it is utilized as a dietary supplement for its potential to support cardiovascular health, primarily through modulation of neurogenic tone and stress response pathways. Its primary bioactive constituents are a group of indole alkaloids, most notably reserpine. This monograph provides a comprehensive, evidence-based review of Serpina, detailing its composition, mechanism of action, clinical applications, and safety profile for the use of healthcare professionals and informed patients.
Symmetrel
Product Monograph: Symmetrel Let’s talk about Symmetrel. It’s one of those agents that sits in a curious niche in the neurologist’s and psychiatrist’s toolkit, often overshadowed by newer, flashier drugs, but it possesses a utility that’s hard to replicate. Its generic name is amantadine hydrochloride. Initially developed as an antiviral for influenza A, its serendipitous discovery in the late 1960s as an anti-parkinsonian agent changed its trajectory. What we have now is a drug with a fascinating, if not fully elucidated, dual mechanism that makes it uniquely valuable for specific, often challenging, clinical scenarios.














